Status:
WITHDRAWN
Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Schizophrenia is a chronic disease with deficit in social interaction and lost of autonomy in daily life. Negative symptoms as blunted affect, avolition, social deficit and anhedonia and cognition wer...
Detailed Description
Schizophrenia is a chronic disease with deficit in social interaction and lost of autonomy in daily life. Negative symptoms as blunted affect, avolition, social deficit and anhedonia and cognition wer...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age \> 18 and \< 60
- Diagnosis of schizophrenia on DSM 5
- criteria of deficit schizophrenia with the schedule for deficit syndrome
- inpatient at inclusion with at least 6 month of hospitalisation during the last 2 years
- clinically stable
- able to understand, talk and read french
- signing consent form
- Exclusion criteria:
- change in psychotropic treatment during the last month
- psychotherapy in the last 8 months or planned during the study
- CDSS score \> 9
- drug dependency during the last year
- unstable somatic disease
- somatic disease with impact on cognition
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03407950
Start Date
January 1 2018
End Date
September 1 2021
Last Update
May 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Delphine CAPDEVIELLE
Montpellier, France, 34295